Water and drug ratio in syrup
Reading File
Finding Sources
Searching the Web
water drug ratio syrup pharmaceutical formulation
Finding Sources
Reading Web Page
https://www.formulationbio.com/syrups.html
Here is a clear breakdown of the water-to-drug ratio in syrups:
Water and Drug Ratio in Syrup (Pharmaceutical)
1. Simple Syrup (No Active Drug)
Simple syrup is the base vehicle used in most oral liquid formulations.
| Pharmacopoeia | Sucrose | Purified Water |
|---|---|---|
| IP (Indian Pharmacopoeia) | 66.67% w/w (667 g per 1000 g) | 33.33% w/w (q.s. to 1000 g) |
| USP (US Pharmacopoeia) | 66.7% w/v (850 g per 1000 mL) | ~33.3% |
So the sucrose-to-water ratio is approximately 2:1 (w/w) in IP and ~2.5:1 (w/v) in USP.
- The sucrose solubility in water is 1 part sucrose in 0.5 parts water (i.e., sucrose dissolves at 1:0.5 ratio).
- Exactly 33.3% water is the minimum needed to dissolve 66.67% sucrose - this is a near-saturated solution.
- The high osmotic pressure at this concentration prevents microbial growth, so no preservative is strictly needed.
- Excess water must be avoided - it dilutes the syrup and makes it prone to microbial contamination.
2. Medicated Syrup (With Active Drug)
In medicated syrups, the active pharmaceutical ingredient (API) is dissolved or suspended in the syrup vehicle. The drug concentration depends entirely on the therapeutic dose, but the general principle is:
- Vehicle (simple syrup) makes up the bulk - typically 60-85% of the total formulation.
- Active drug is present in a much smaller quantity (milligram range per dose).
- Purified water is the primary solvent; sucrose/syrup provides sweetness, viscosity, and preservative action.
Example - typical medicated syrup structure:
| Component | Approximate % |
|---|---|
| Sucrose | 50-66% |
| Purified Water | 25-40% |
| Active Drug | 0.1-5% (varies widely) |
| Preservatives, flavors, colors | < 1-2% |
3. Key Formulation Points
- Sucrose inversion: Excessive heating converts sucrose (C₁₂H₂₂O₁₁) into invert sugar (glucose + fructose), which causes browning and fermentation. Avoid prolonged boiling.
- Antimicrobial protection: The high sugar concentration (66.67%) creates high osmotic pressure that inhibits microbial growth. If the concentration is lower, preservatives like 0.15% methyl paraben must be added.
- Preparation methods: Solution with heat (thermostable drugs), agitation without heat (volatile/heat-sensitive drugs), addition of sucrose to liquid medicament, and percolation.
In summary: the standard simple syrup ratio is 2 parts sucrose : 1 part water (w/w). For medicated syrups, water typically constitutes 25-40% of the total formulation, with the drug being a minor constituent whose exact amount is determined by the therapeutic dose requirement.
Raw material in drugs
Finding Sources
Searching the Web
raw materials in pharmaceutical drug formulation API excipients types
Finding Sources
Reading Web Page
https://www.simsonpharma.com/blog-details/types-of-raw-mater…
Here is a complete overview of raw materials used in pharmaceutical drug manufacturing:
Raw Materials in Pharmaceutical Drugs
A pharmaceutical raw material is any substance or ingredient used in the production of drugs and medications. They are the building blocks of every medicine and can be natural, synthetic, or semi-synthetic.
Classification of Raw Materials
Raw materials in pharmaceuticals fall into two broad groups:
1. Active Pharmaceutical Ingredients (API)
The API is the core component of a drug - the substance that produces the intended therapeutic effect.
| Feature | Details |
|---|---|
| Also called | Drug substance, active ingredient |
| Source | Synthetic (chemical), natural (plant/animal), biological (biotech), semi-synthetic |
| Examples | Paracetamol, amoxicillin, insulin, aspirin |
| Quality requirement | Must meet strict purity, potency, and stability standards |
- APIs are produced through chemical synthesis, fermentation, or extraction from natural sources.
- Intermediates are compounds formed during API synthesis - they are not the final API but are precursors to it.
2. Excipients (Inactive Ingredients)
Excipients are pharmacologically inactive substances that support the API in the formulation. They do not produce a therapeutic effect themselves but are essential for:
- Drug delivery and absorption
- Stability during storage
- Palatability and ease of administration
- Manufacturing processability
Types of Excipients by Function
| Type | Function | Examples |
|---|---|---|
| Binders | Hold tablet ingredients together | Starch, PVP (polyvinylpyrrolidone), HPMC |
| Fillers / Diluents | Bulk up the tablet to a manageable size | Lactose, microcrystalline cellulose, calcium phosphate |
| Disintegrants | Help the tablet break apart in GI tract | Croscarmellose sodium, sodium starch glycolate |
| Lubricants | Prevent sticking to machinery during tablet press | Magnesium stearate, talc, stearic acid |
| Glidants | Improve powder flow | Colloidal silicon dioxide |
| Preservatives | Prevent microbial growth (liquids, creams) | Methyl paraben, benzalkonium chloride |
| Stabilizers | Maintain drug potency and prevent degradation | Antioxidants (BHA, BHT), chelating agents |
| Solvents / Vehicles | Dissolve/suspend the drug | Purified water, ethanol, propylene glycol |
| Sweeteners | Improve taste (oral liquids) | Sucrose, saccharin, sorbitol |
| Flavors & Colors | Improve acceptability | Peppermint oil, tartrazine |
| Emulsifiers | Stabilize emulsions | Lecithin, polysorbate 80 |
| Coating agents | Protect tablet, mask taste, control release | HPMC, ethyl cellulose, shellac |
3. Solvents
Used during manufacturing (synthesis, granulation, coating) or as part of the final product (injections, oral liquids).
- Examples: Water for injection (WFI), ethanol, acetone, isopropyl alcohol
- Must be removed to safe residual limits in final products (ICH Q3C guidelines)
4. Natural Source Raw Materials
| Source | Examples |
|---|---|
| Plant-derived | Morphine (opium poppy), digoxin (foxglove), atropine (belladonna), artemisinin |
| Animal-derived | Insulin (porcine/bovine), heparin, gelatin (capsule shells) |
| Microbial/Fermentation | Penicillin, erythromycin, statins |
5. Biological Raw Materials
Used in production of vaccines, monoclonal antibodies, blood products, and gene therapies:
- Cell culture media
- Growth factors
- Viral vectors
- Recombinant proteins
6. Packaging Materials
Although not part of the drug formulation itself, these are classified as raw materials in pharmaceutical manufacturing:
- Glass/plastic bottles, blister packs (PVC/aluminium foil)
- Rubber stoppers (for injectables)
- Labels and inserts
- Must be inert and not interact with the drug
Quality and Regulatory Requirements
All pharmaceutical raw materials must comply with pharmacopoeial standards:
- IP (Indian Pharmacopoeia), BP (British), USP (United States), EP (European)
- GMP (Good Manufacturing Practice) guidelines govern sourcing, testing, storage, and handling
- Each batch of raw material undergoes identity testing, purity testing, microbial testing, and potency assessment before release
In summary, every drug contains at minimum two categories of raw material: the API (which cures or treats) and excipients (which make the API deliverable, stable, and acceptable to the patient). The ratio and choice of these materials determine the drug's efficacy, safety, stability, and bioavailability.
In which form
Finding Sources
Searching the Web
physical forms of pharmaceutical raw materials API excipients powder crystal liquid
Here is a detailed breakdown of the physical forms in which raw materials exist in pharmaceutical drugs:
Physical Forms of Raw Materials in Pharmaceuticals
1. SOLID Forms
Solids are the most common form for both APIs and excipients.
| Solid Form | Description | Examples |
|---|---|---|
| Crystalline powder | Most APIs are crystalline - molecules arranged in a regular lattice | Paracetamol, aspirin, ibuprofen |
| Amorphous powder | No defined crystal structure; higher solubility but less stable | Some spray-dried APIs |
| Polymorphs | Same drug in different crystal arrangements - affects solubility & bioavailability | Ranitidine, chloramphenicol |
| Granules | Larger aggregates of powder particles formed by granulation | Excipient blends in tablet manufacturing |
| Pellets | Small spherical units used in capsules or controlled release | Modified release formulations |
| Lyophilized (freeze-dried) powder | Dried from frozen solution; reconstituted before use | Injectables: amoxicillin-clavulanate |
| Microcrystalline | Fine crystalline form with improved compressibility | Microcrystalline cellulose (MCC) |
2. LIQUID Forms
Used directly in formulations or as solvents/processing aids.
| Liquid Form | Description | Examples |
|---|---|---|
| Aqueous solution | Drug dissolved in purified water | Water for injection, oral solutions |
| Oils | Vegetable or mineral oils as vehicles | Arachis oil, castor oil (for injectables, capsules) |
| Liquid APIs | Some APIs are naturally liquid | Liquid paraffin, glycerin, ethanol |
| Solvents | Used in synthesis, granulation, coating | Ethanol, isopropyl alcohol, acetone, dichloromethane |
| Suspending agents (liquid) | Liquid polymers or gums | Xanthan gum solution, CMC solution |
3. SEMI-SOLID Forms
Mainly used for topical and special formulations.
| Form | Description | Examples |
|---|---|---|
| Waxes | Solid at room temp, semi-solid when melted | Beeswax, carnauba wax (coating, suppositories) |
| Gels / Hydrogels | Polymer networks swollen in water | Carbomer, HPMC gel (topical, ophthalmic) |
| Fats / Fatty bases | Semi-solid lipid materials | Theobroma oil (cocoa butter) - suppository base |
| Petrolatum/Ointment bases | Semi-solid petroleum derivatives | White soft paraffin |
4. GASEOUS Forms
Less common but used in specific applications.
- Propellants in pressurized metered-dose inhalers (pMDIs): HFA-134a, HFA-227ea
- Sterilizing gases: Ethylene oxide (used in sterilization of equipment)
- Medical gases: Oxygen, nitrogen (used in packaging/purging to prevent oxidation)
Summary Table
| Physical State | Used As | Examples |
|---|---|---|
| Crystalline solid | API, filler, binder | Paracetamol, lactose, sucrose |
| Amorphous solid | API (improved solubility) | Spray-dried dispersions |
| Lyophilized powder | Injectable API | Vancomycin, ceftriaxone |
| Liquid | Solvent, vehicle, liquid API | Ethanol, water, glycerin |
| Oil | Vehicle, solvent | Castor oil, arachis oil |
| Semi-solid / wax | Coating, suppository base | Beeswax, cocoa butter |
| Gas / aerosol | Propellant | HFA-134a |
Why Physical Form Matters
- Solubility and bioavailability - crystalline vs. amorphous forms dissolve at different rates
- Stability - amorphous forms are less stable than crystalline; hygroscopic powders absorb moisture
- Processing - powders must flow freely; particle size affects tablet uniformity
- Polymorphism - different crystal forms of the same API can have drastically different therapeutic effects (this is tightly regulated by pharmacopoeias)
- Storage - some raw materials require cold chain (biologicals), nitrogen atmosphere (oxidation-sensitive), or humidity-controlled conditions
In short, raw materials can arrive at a pharmaceutical manufacturer as fine powders, crystals, granules, liquids, oils, semi-solids, or lyophilized cakes - the physical form is chosen based on the drug's chemistry, route of administration, and manufacturing process.
This is a shared conversation. Sign in to Orris to start your own chat.